Heteroatoms-containing tricyclic compounds

Details for Australian Patent Application No. 2005293799 (hide)

Owner Novartis AG

Inventors Horvath, Amarylla; Grassberger, Maximilian

Agent Davies Collison Cave

Pub. Number AU-B-2005293799

PCT Pub. Number WO2006/040111

Priority 0427599.6 16.12.04 GB; 0422643.7 12.10.04 GB

Filing date 10 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 26 February 2009

International Classifications

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07H 19/01 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/040111 Priority application(s): WO2006/040111

26 February 2009 Application Accepted

  Published as AU-B-2005293799

25 June 2009 Standard Patent Sealed

26 April 2012 Assignment Registered

  Novartis AG The patent has been assigned to MEDA Pharma S.a.r.l. Assignments Registered

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293800-Taste-masking pharmaceutical compositions

2005293789-Free-flowing thermoplastics with halogen flameproofing